Blog
RSS FeedPosted by Michael Wonder on 26 Jan 2017
Approval of proposal for clostridium botulinum type A toxin (Botox) in DHB hospitals
26 January 2017 - PHARMAC is pleased to announce the approval of an agreement with Allergan to amend the contractual ...
Posted by Michael Wonder on 16 Jan 2017
How Pharmac stole my holiday
16 January 2017 - Earlier this month I went to the chemist and got a new prescription filled to take ...
Posted by Michael Wonder on 01 Jan 2017
New Zealand Pharmaceutical Schedule - 1 January 2017
1 January 2017 - The January 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Dec 2016
Decision to list oral betaine for rare disorder
21 December 2016 - PHARMAC is pleased to announce the approval of an agreement with Emerge Health to list oral ...
Posted by Michael Wonder on 20 Dec 2016
Proposal to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
20 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of funding for gefitinib ...
Posted by Michael Wonder on 18 Dec 2016
AFT to re-apply for heart medicine contract after shortages
16 December 2016 - AFT Pharmaceuticals, the Auckland-based drug-maker, will have to re-apply to Pharmac for a heart medicine supply ...
Posted by Michael Wonder on 15 Dec 2016
Decision relating to anti-VEGF treatments for ophthalmic use
15 December 2016 - On 5 September 2016, PHARMAC consulted on a proposal to list ranibizumab (Lucentis) and aflibercept (Eylea) ...
Posted by Michael Wonder on 14 Dec 2016
Somatropin for patients under 2 years with Prader-Willi Syndrome
14 December 2016 - PHARMAC is pleased to announce that somatropin (human growth hormone) will be fully funded for patients ...
Posted by Michael Wonder on 13 Dec 2016
Children of woman with rare disease ask Santa for 'mummy's medicine'
13 December 2016 - Two Kiwi children whose mother is fighting for life-saving treatment have asked Santa for "mummy's medicine" ...
Posted by Michael Wonder on 08 Dec 2016
Decision regarding PHARMAC’s implementation of Trans-Pacific Partnership provisions and other amendments to application processes
8 December 2016 - PHARMAC is pleased to announce that changes will be made to its Operating Policies and Procedures ...
Posted by Michael Wonder on 06 Dec 2016
Heartless' to deny breast cancer drug
5 December 2016 - The Breast Cancer Foundation is demanding approval granted for a new drug be extended to those already ...
Posted by Michael Wonder on 06 Dec 2016
Clostridium botulinum type A toxin (Botox) in DHB hospitals
6 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of listing for clostridium botulinum ...
Posted by Michael Wonder on 05 Dec 2016
PHARMAC funds breast cancer drug Perjeta
5 December 2016 - More breast cancer sufferers will soon have access to a treatment programme that can extend lives ...
Posted by Michael Wonder on 04 Dec 2016
Approval of multi-product funding proposal with Roche
5 December 2016 - PHARMAC is pleased to announce a major funding package following an agreement with Roche for funding ...
Posted by Michael Wonder on 30 Nov 2016
New Zealand Pharmaceutical Schedule - 1 December 2016
1 December 2016 - The December 2016 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...